
Neovasc NVCN
Annual report 2021
added 12-23-2023
Neovasc P/S Ratio 2011-2025 | NVCN
Annual P/S Ratio Neovasc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 266 | 99 | 244 | 148 | 208 | 9.08 | 29.6 | 35.8 | 17.5 | 12.9 | 10.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 266 | 9.08 | 98.1 |
P/S Ratio of other stocks in the Medical devices industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
0.0191 | - | - | $ 17.2 B | ||
|
Alphatec Holdings
ATEC
|
2.54 | $ 21.09 | 0.6 % | $ 3.01 B | ||
|
Acutus Medical
AFIB
|
0.731 | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
0.667 | - | 3.58 % | $ 2.21 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
5.44 | - | - | $ 1.77 B | ||
|
Lianluo Smart Limited
LLIT
|
409 | - | 24.59 % | $ 44.8 M | ||
|
Cognyte Software Ltd.
CGNT
|
1.61 | $ 9.27 | -0.43 % | $ 666 M | ||
|
Apyx Medical Corporation
APYX
|
0.873 | $ 3.51 | 2.09 % | $ 122 M | ||
|
Boston Scientific Corporation
BSX
|
9.26 | $ 95.87 | -0.16 % | $ 141 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
22 | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
3.04 | $ 303.07 | -0.27 % | $ 8.55 B | ||
|
Apollo Endosurgery
APEN
|
5.24 | - | - | $ 475 M | ||
|
Conformis
CFMS
|
0.204 | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
2.49 | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
0.939 | - | -10.19 % | $ 1.99 M | ||
|
BioSig Technologies
BSGM
|
183 | - | 37.08 % | $ 85.7 M | ||
|
Electromed
ELMD
|
2.73 | $ 28.32 | -0.63 % | $ 239 M | ||
|
Bruker Corporation
BRKR
|
0.000002 | $ 48.17 | 0.33 % | $ 7.18 K | ||
|
Abbott Laboratories
ABT
|
5.6 | $ 124.83 | - | $ 217 B | ||
|
Eargo
EAR
|
0.456 | - | - | $ 10.2 M | ||
|
EDAP TMS S.A.
EDAP
|
5.1 | $ 3.27 | -3.97 % | $ 122 M | ||
|
CryoLife, Inc.
CRY
|
3.58 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
0.19 | - | 1.15 % | $ 34.5 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
1.88 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
8.25 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
2.96 | - | - | $ 462 M | ||
|
InMode Ltd.
INMD
|
11 | $ 14.8 | 1.22 % | $ 1.17 B | ||
|
IRIDEX Corporation
IRIX
|
0.927 | $ 1.16 | -5.69 % | $ 18.7 M | ||
|
IRadimed Corporation
IRMD
|
9.14 | $ 97.61 | 0.16 % | $ 1.24 B | ||
|
Dynatronics Corporation
DYNT
|
0.0712 | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
9.12 | - | - | $ 955 M | ||
|
LivaNova PLC
LIVN
|
1.82 | $ 62.08 | -1.26 % | $ 3.37 B | ||
|
LENSAR
LNSR
|
2.43 | $ 11.96 | 0.04 % | $ 138 M | ||
|
Second Sight Medical Products
EYES
|
44.4 K | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
3.48 | $ 157.99 | -0.24 % | $ 11.8 B | ||
|
NanoVibronix
NAOV
|
0.36 | - | - | $ 1.08 M | ||
|
Accuray Incorporated
ARAY
|
0.35 | $ 0.81 | -2.36 % | $ 83.2 M | ||
|
Avinger
AVGR
|
0.339 | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
14.8 | $ 13.6 | -3.0 % | $ 368 M | ||
|
FONAR Corporation
FONR
|
0.873 | $ 14.46 | 0.06 % | $ 94.8 M | ||
|
AxoGen
AXGN
|
4.59 | $ 32.84 | 0.12 % | $ 1.45 B | ||
|
Axonics Modulation Technologies
AXNX
|
10.3 | - | - | $ 3.31 B | ||
|
GBS
GBS
|
0.812 | - | -0.57 % | $ 7.12 M | ||
|
CONMED Corporation
CNMD
|
1.48 | $ 41.4 | 1.55 % | $ 1.28 B | ||
|
OrthoPediatrics Corp.
KIDS
|
2.88 | $ 17.8 | 2.65 % | $ 411 M | ||
|
Globus Medical
GMED
|
4.54 | $ 88.69 | 0.32 % | $ 12 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.17 | $ 12.55 | -0.55 % | $ 966 M | ||
|
Orthofix Medical
OFIX
|
0.837 | $ 15.47 | 1.51 % | $ 590 M |